Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Joyce

Showing results (111-120 of 142) with videos related to

Pageof 15
Sort By:
Advanced Drug Delivery Reviews|December 12, 2018
Solidification to improve the biopharmaceutical performance of SEDDS: Opportunities and challengesPaul Joyce, Tahnee J Dening, Tahlia R Meola, et al.
Applied and Environmental Microbiology|May 5, 2005
Use of stochastic models to assess the effect of environmental factors on microbial growthJosé Miguel Ponciano, Frederik P J Vandecasteele, Thomas F Hess, et al.
Journal of Pharmaceutical Sciences|September 26, 2020
A Comparison of Chitosan, Mesoporous Silica and Poly(lactic-co-glycolic) Acid Nanocarriers for Optimising Intestinal Uptake of Oral Protein TherapeuticsLeah Wright, Paul Joyce, Timothy J Barnes, et al.
Egastroenterology|February 13, 2025
Prebiotic selection influencing inflammatory bowel disease treatment outcomes: a review of the preclinical and clinical evidenceAmin Ariaee, Sabrina Koentgen, Hannah R Wardill, et al.
G3 (Bethesda, Md.)|February 28, 2016
Genetically Determined Variation in Lysis Time Variance in the Bacteriophage φX174Christopher W Baker, Craig R Miller, Tanayott Thaweethai, et al.
Pharmaceutics|February 24, 2024
Combating Acute Myeloid Leukemia via Sphingosine Kinase 1 Inhibitor-Nanomedicine Combination Therapy with Cytarabine or VenetoclaxThao M Nguyen, Paul Joyce, David M Ross, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 11, 2026
Gut microbiota perturbation and systemic inflammation are associated with salcaprozate sodium (SNAC)-enabled oral semaglutide deliveryAmin Ariaee, Karim Noueihad, Alex Hunter, et al.
ACS Infectious Diseases|January 31, 2024
Minimum Information for Conducting and Reporting <i>In Vitro</i> Intracellular Infection AssaysSanthni Subramaniam, Paul Joyce, Abiodun D Ogunniyi, et al.
Alimentary Pharmacology & Therapeutics|July 1, 2026
Review Article: The Impact of the Gut Microbiome on Ulcerative Colitis PharmacotherapyKate Collins, Srinivas Kamath, Rachel H Davis, et al.
Molecular Pharmaceutics|March 3, 2022
Role of Silica Intrawall Microporosity on Abiraterone Acetate Solubilization and <i>In Vivo</i> Oral AbsorptionRuba Almasri, Hayley B Schultz, Amalie Møller, et al.
Pageof 15

Showing results (111-120 of 142) with videos related to

Sort By:
Pageof 15
Advanced Drug Delivery Reviews|December 12, 2018
Solidification to improve the biopharmaceutical performance of SEDDS: Opportunities and challengesPaul Joyce, Tahnee J Dening, Tahlia R Meola, et al.
Applied and Environmental Microbiology|May 5, 2005
Use of stochastic models to assess the effect of environmental factors on microbial growthJosé Miguel Ponciano, Frederik P J Vandecasteele, Thomas F Hess, et al.
Journal of Pharmaceutical Sciences|September 26, 2020
A Comparison of Chitosan, Mesoporous Silica and Poly(lactic-co-glycolic) Acid Nanocarriers for Optimising Intestinal Uptake of Oral Protein TherapeuticsLeah Wright, Paul Joyce, Timothy J Barnes, et al.
Egastroenterology|February 13, 2025
Prebiotic selection influencing inflammatory bowel disease treatment outcomes: a review of the preclinical and clinical evidenceAmin Ariaee, Sabrina Koentgen, Hannah R Wardill, et al.
G3 (Bethesda, Md.)|February 28, 2016
Genetically Determined Variation in Lysis Time Variance in the Bacteriophage φX174Christopher W Baker, Craig R Miller, Tanayott Thaweethai, et al.
Pharmaceutics|February 24, 2024
Combating Acute Myeloid Leukemia via Sphingosine Kinase 1 Inhibitor-Nanomedicine Combination Therapy with Cytarabine or VenetoclaxThao M Nguyen, Paul Joyce, David M Ross, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 11, 2026
Gut microbiota perturbation and systemic inflammation are associated with salcaprozate sodium (SNAC)-enabled oral semaglutide deliveryAmin Ariaee, Karim Noueihad, Alex Hunter, et al.
ACS Infectious Diseases|January 31, 2024
Minimum Information for Conducting and Reporting <i>In Vitro</i> Intracellular Infection AssaysSanthni Subramaniam, Paul Joyce, Abiodun D Ogunniyi, et al.
Alimentary Pharmacology & Therapeutics|July 1, 2026
Review Article: The Impact of the Gut Microbiome on Ulcerative Colitis PharmacotherapyKate Collins, Srinivas Kamath, Rachel H Davis, et al.
Molecular Pharmaceutics|March 3, 2022
Role of Silica Intrawall Microporosity on Abiraterone Acetate Solubilization and <i>In Vivo</i> Oral AbsorptionRuba Almasri, Hayley B Schultz, Amalie Møller, et al.
Pageof 15